Abstract

TGF-βs 1–3 are secreted from the cells as latent complexes composed of dimeric mature growth factors, the respective N-terminal propeptides latency-associated peptide (LAP) and one of the four latent TGF-β binding proteins (LTBPs). The non-covalently associated LAP renders each mature TGF-β latent; they cannot bind to the cell surface receptors and mediate their effects. LTBPs augment the secretion of each small latent complex and directs them to the extracellular matrix. The activation of TGF-β (release of mature TGF-β from the latent complex) is a central way to control the activity of TGF-β. The activation can be achieved by several proteinases, by the extracellular matrix (ECM) glycoprotein thrombospondin-1 and via a subset of cell surface integrins. Similarly, the association of the propeptides TGF-βs with different LTBPs, and subsequent different localization to the extracellular space, and potentially differential susceptibility to the activation events regulate the availability of each TGF-β: in an efficient and specific manner.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.